Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo-)adjuvant chemo-radiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial

Hofheinz, R-D and Wenz, F. and Post, S. and Matzdorff, A. and Laechelt, S. and Hartmann, J. T. and Mueller, L. and Link, H. and Moehler, M. and Kettner, E. and Fritz, E. and Hieber, U. and Lindemann, H. W. and Grunewald, M. and Kremers, S. and Constantin, C. and Hipp, M. and Gencer, D. and Burkholder, I and Hochhaus, A. (2011) Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo-)adjuvant chemo-radiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial. ONKOLOGIE, 34 (Suppl6). p. 199. ISSN 0378-584X

Full text not available from this repository.

Item Type:	Article
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Strahlentherapie
Depositing User:	Petra Gürster
Date Deposited:	05 May 2020 05:48
Last Modified:	05 May 2020 05:48
URI:	https://pred.uni-regensburg.de/id/eprint/20265

Actions (login required)

View Item